Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Xolremdi mavorixafor 4/26/2024 To treat WHIM syndrome (warts, hypogammaglobulinemia,
May 012024
Apr 232024
Apr 082024
Date Brand Name(s) Description Type Reason Company 4/8/2024 Medline and Centurion Convenience kits Medical Devices The potential for a lack of sterility Medline Industries, LP
Apr 052024
Apr 012024
Apr 012024
Date Brand Name(s) Description Type Reason Company 4/1/2024 AVpak Atovaquone Oral Suspension, USP 750mg/5mL Drugs Potential Bacillus cereus contamination AvKARE, LLC
Mar 282024
Mar 272024
Mar 202024
Mar 182024
